Skip to content
10-K

Annual Report

Evolent Health, Inc. EVH

0001628908-26-000015

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 16, 2026 111.64M sh
Shares Diluted FY 2025 · Dec 31, 2025 114.21M sh
Shares Diluted FY 2025 · Dec 31, 2024 114.68M sh
Shares Diluted FY 2025 · Dec 31, 2023 111.25M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $40M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 $38.84M
Operating Cash Flow FY 2025 · Dec 31, 2024 $18.77M
Operating Cash Flow FY 2025 · Dec 31, 2023 $142.58M
Long Term Debt FY 2025 · Dec 31, 2025 $970.54M
Long Term Debt FY 2025 · Dec 31, 2024 $490.52M
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $171.47M
Cash And Equivalents FY 2025 · Dec 31, 2025 $151.86M
Cash And Equivalents FY 2025 · Dec 31, 2024 $104.2M
Stockholders Equity FY 2025 · Dec 31, 2025 $415.19M
Stockholders Equity FY 2025 · Dec 31, 2024 $1B
Stockholders Equity FY 2025 · Dec 31, 2023 $1.07B
Stockholders Equity FY 2025 · Dec 31, 2022 $859.42M
Current Liabilities FY 2025 · Dec 31, 2025 $385.26M
Current Liabilities FY 2025 · Dec 31, 2024 $715.5M
Total Liabilities FY 2025 · Dec 31, 2025 $1.48B
Total Liabilities FY 2025 · Dec 31, 2024 $1.35B
Current Assets FY 2025 · Dec 31, 2025 $506.37M
Current Assets FY 2025 · Dec 31, 2024 $607.12M
Total Assets FY 2025 · Dec 31, 2025 $1.9B
Total Assets FY 2025 · Dec 31, 2024 $2.54B
Eps Diluted FY 2025 · Dec 31, 2025 −$3.84
Eps Diluted FY 2025 · Dec 31, 2025 −$5.07
Eps Diluted FY 2025 · Sep 30, 2025 −$0.24
Eps Diluted FY 2025 · Jun 30, 2025 −$0.44
Eps Diluted FY 2025 · Mar 31, 2025 −$0.63
Eps Diluted FY 2025 · Dec 31, 2024 −$0.27
Eps Diluted FY 2025 · Dec 31, 2024 −$0.81
Eps Diluted FY 2025 · Sep 30, 2024 −$0.27
Eps Diluted FY 2025 · Jun 30, 2024 −$0.06
Eps Diluted FY 2025 · Mar 31, 2024 −$0.22
Eps Diluted FY 2025 · Dec 31, 2023 −$1.28
Eps Basic FY 2025 · Dec 31, 2025 −$3.84
Eps Basic FY 2025 · Dec 31, 2025 −$5.07
Eps Basic FY 2025 · Sep 30, 2025 −$0.24
Eps Basic FY 2025 · Jun 30, 2025 −$0.44
Eps Basic FY 2025 · Mar 31, 2025 −$0.63
Eps Basic FY 2025 · Dec 31, 2024 −$0.27
Eps Basic FY 2025 · Dec 31, 2024 −$0.81
Eps Basic FY 2025 · Sep 30, 2024 −$0.27
Eps Basic FY 2025 · Jun 30, 2024 −$0.06
Eps Basic FY 2025 · Mar 31, 2024 −$0.22
Eps Basic FY 2025 · Dec 31, 2023 −$1.28
Sga Expense FY 2025 · Dec 31, 2025 $303.87M
Sga Expense FY 2025 · Dec 31, 2024 $263.05M
Sga Expense FY 2025 · Dec 31, 2023 $358.11M
Net Income FY 2025 · Dec 31, 2025 −$429.13M
Net Income FY 2025 · Dec 31, 2025 −$534.51M
Net Income FY 2025 · Sep 30, 2025 −$20.86M
Net Income FY 2025 · Jun 30, 2025 −$19.9M
Net Income FY 2025 · Mar 31, 2025 −$64.62M
Net Income FY 2025 · Dec 31, 2024 −$22.8M
Net Income FY 2025 · Dec 31, 2024 −$61.62M
Net Income FY 2025 · Sep 30, 2024 −$23.14M
Net Income FY 2025 · Jun 30, 2024 $1.6M
Net Income FY 2025 · Mar 31, 2024 −$17.28M
Net Income FY 2025 · Dec 31, 2023 −$113.04M
Operating Income FY 2025 · Dec 31, 2025 −$410.14M
Operating Income FY 2025 · Dec 31, 2024 −$40.49M
Operating Income FY 2025 · Dec 31, 2023 −$71.21M
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.48B
Cost Of Revenue FY 2025 · Dec 31, 2024 $2.19B
Cost Of Revenue FY 2025 · Dec 31, 2023 $1.5B
Revenue FY 2025 · Dec 31, 2025 $468.72M
Revenue FY 2025 · Dec 31, 2025 $1.88B
Revenue FY 2025 · Sep 30, 2025 $479.53M
Revenue FY 2025 · Jun 30, 2025 $444.33M
Revenue FY 2025 · Mar 31, 2025 $483.65M
Revenue FY 2025 · Dec 31, 2024 $646.54M
Revenue FY 2025 · Dec 31, 2024 $2.55B
Revenue FY 2025 · Sep 30, 2024 $621.4M
Revenue FY 2025 · Jun 30, 2024 $647.15M
Revenue FY 2025 · Mar 31, 2024 $639.65M
Revenue FY 2025 · Dec 31, 2023 $1.96B